Navigation Links
DNDi expands activities to neglected patient needs in the field of helminth infections
Date:7/8/2011

i. "Such a drug could be used as an alternative preventive treatment with a major public health impact."

In addition to addressing the specific and urgent needs of co-infected patients, a new macrofilaricide could significantly reduce treatment cycles even for areas that are not burdened by co-infection, since it would no longer be necessary to wait until the adult worm dies, which can take up to 12 years. It could reduce current the MDA treatment cycle to approximately 2 to 3 years, making the diseases easier to control.

"The first step of this project is to assess the safety profile in pre-clinical studies to further reformulate flubendazole and develop a safe, highly efficacious, and field-adapted macrofilaricidal drug candidate," explains Dr. Charles MacKenzie of Michigan State University, who was involved in early work on flubendazole. "Flubendazole is the only macrofilaricide candidate on the horizon that has demonstrated positive in vivo results."

DNDi is partnering with Michigan State University in the US, and McGill University in Canada, for the pharmacodynamic studies; the generic pharmaceutical company Advinus Therapeutics, in India, for the toxicology and the pharmacokinetics studies; and Drugabilis and Bertin Pharma, France, for the pre-formulation and formulation of the drug, respectively.

"Without new tools adapted to the needs of patients in the poorest and remote areas of the world it will be difficult, if not impossible, to eliminate some of the most common neglected tropical diseases," said Dr. Bernard Pcoul, Executive Director of DNDi. "To achieve sustainable control and potential elimination of helminth infections, we need to both improve implementation of existing tools and develop better drugs for patients in whom current treatments do not work."

The initial investigations by DNDi to assess its helminth drug portfolio were made possible with the financial support of Doctors Without Borders/Mdecins S
'/>"/>

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. National High Value Healthcare Collaborative expands
2. Brazils health care system vastly expands coverage, but universality, equity remain elusive
3. Brachytherapy, the official journal of ABS, expands to 6 issues in 2011
4. Deep brain stimulation research expands at Barrow
5. Overabundance of protein expands breast cancer stem cells
6. Autism Speaks Autism Treatment Network expands to 17 sites in North America
7. NIH expands food allergy research program
8. Microfluidics Expands Partnership with Particle Sciences to Include Continuous Crystallization Capabilities
9. DNV Healthcare Inc. Expands to New Administrative Headquarters for US Hospital Accreditation Services
10. MISI Company, Ltd. Acquires Cue Data Services and Expands Geographically to New England and Canada
11. Brilliance Weight Loss Expands Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... ... From the moment a patient enters the office of Dr. Breiterman at ... and the luxury in which they are bathed. The office has always offered ... same experience, just better! , Their office is a state-of the-art facility using only ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice that ... of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research ...
(Date:6/30/2015)... ... 30, 2015 , ... Independence Day weekend is more than just fireworks to ... off of July as National Hot Dog Month. Americans are expected to eat more ... of the year and enough to stretch from Washington D.C. to Los Angeles more ...
(Date:6/30/2015)... Nashville, Tennessee (PRWEB) , ... ... ... provider of CorrectChemo®, the drug response profiling test to help oncologists provide ... GeneSourceTM. , “The CorrectChemo® assay provides the oncologist with valuable insight ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3
... Inc. (Nasdaq: NPSP ) announced today that it ... 2008 post-market. The,announcement will be followed by a conference ... participate in the conference call, dial (866) 510-0708 and ... the,same passcode. In addition, a live audio of the ...
... cardiovascular threats, study suggests , , THURSDAY, March 6 (HealthDay ... also be reducing their risk of heart attack and ... rheumatoid arthritis (RA), which causes pain, swelling, stiffness and ... risk of cardiovascular disease, because it can lead to ...
... Empire Blue Cross Blue Shield has,been fully cooperating ... issue to our attention., We were also surprised ... diligent in our efforts to determine whether the,information provided ... share,data with the Attorney General,s office in accordance with ...
... 418% versus 2006 ... 32% versus Q3 2007, VANCOUVER, March 6 /PRNewswire-FirstCall/ - ... $3.25 million for,the year ended December 31, 2007 compared to ... of 418%. The Company,s net loss,decreased to $3.5 million ($0.08) ...
... A study released this week from researchers ... California shows that non-polypoid colorectal neoplasms or flat colon ... and may have a greater association with cancer compared ... polyp. The study appears in the March 5 issue ...
... ,Smith & Nephew, Inc. (NYSE: SNN ; ... launch of the R3(TM) Acetabular System,an advanced multi-bearing ... The announcement was made during the 75th annual,American ... in the world, in San Francisco., The ...
Cached Medicine News:Health News:NPS Pharmaceuticals to Report 2007 Financial Results 2Health News:Rheumatoid Arthritis Drugs May Lower Heart Attack, Stroke Risk 2Health News:CRH Medical reports preliminary year end results 2Health News:CRH Medical reports preliminary year end results 3Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion 2Health News:Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion 3
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Top-line Data Expected in August -, EXTON, ... today the completion of the pivotal efficacy portion ... Isolagen,Therapy(TM) for the treatment of nasolabial folds, or ... the primary efficacy follow-up visit,and collation of this ...
... ... Professionals, VOORHEES, N.J., July 1 ... a wide spectrum of,severity, ranging from mild diarrhea to pseudomembranous colitis ... who develop an initial,case of CDI.(1) These patients are at increased ...
Cached Medicine Technology:Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: